Conversion Plan of the Company of which a plan for allocation and offering of the newly issued ordinary shares of the Company according to the Debt to Equity Conversion Scheme, was a part thereof. This would
for producing of HRC to increase the normal capacity during off peak power usage in 4th Quarter of 2017. - Gain from debt restructuring was achieved of THB 734 million some portion resulting from debt
due to the Debt restructuring scheme and repayment. 5. Short-term loan from other party decreased by THB 19 million due to the Company’s repayment. 6. Liabilities under rehabilitation plan decreased by
accordingly (for year 2016: sale volumes and production volumes at 187,043 tons and 189,008 tons in accordingly) - Gain from debt restructuring was achieved of THB 110 million resulting from debt-to- equity
64 million. In addition, the company has continued its plan to proceed on the debts restructuring with aim to strengthen the financial status, reduce the burden of interest payment and improve
transaction : The Company has a plan to do the potential growth business especially health and aging society business relating with the main business of the Company, medical device business. Value of
1,848per ton in 2017. Management’s Discussion and Analysis (MD&A) for year 2017 2 As the result of EGM holding on 30 August 2017, the shareholders voted down the Debt Equity conversion. On 13 November 2017
activities Finance costs paid (776) Payment of liabilities under rehabilitation plan (18) Payment of liabilities during debt restructuring (922) Proceeds(Repayment)of short-term loans from financial
headroom of approximately $7 billion (based on budgets and our internal guideline of 1:1 Net Debt: Equity over the plan period). Investments from this headroom includes acquisitions announced. Table 4